Summary
25 years have elapsed since the introduction of the first effective oral diuretic, chlorothiazide. Diuretics are now amongst the most widely prescribed drugs in clinical practice worldwide. Availability of these drugs has not only brought therapeutic benefit to countless numbers of patients but it has at the same time provided valuable research tools with which to investigate the functional behaviour of the kidney and other electrolyte-transporting tissues.
Despite many remaining gaps in our knowledge of the biochemical processes involved in diuretic drug action, available compounds can be divided into 5 groups on the basis of their preferential effects on different segments of the nephron involved in tubular reabsorption of sodium chloride and water. Firstly, there is a heterogeneous group of chemicals that share the common property of powerful, short- lived diuretic effects that are complete within 4 to 6 hours. These agents act on the thick ascending limb of Henle’s loop and are known as ‘high ceiling’ or ‘loop’ diuretics. The second group are the benzothiadiazines and their many related heterocyclic variants, all of which localise their effects to the early portion of the distal tubule. The third group comprises the potassium- sparing diuretics which act exclusively on the Na+- K+/H+ exchange mechanisms in the late distal tubule and cortical collecting duct. The action of drugs in groups 2 and 3 is prolonged to between 12 and 24 hours. The fourth group consists of diuretics that are chemically related to ethacrynic acid but have the unusual property of combining within the same molecule the property of saluresis and uricosuria. These compounds have actions, to different individual extents, in the proximal tubule, thick ascending limb, and early distal tubule and are known as ‘polyvalent’ diuretics. Finally, there is a mixed group of weak or adjunctive diuretics which includes the vasodilator xanthines such as aminophylline, and the osmotically active compounds such as mannitol.
Available evidence on the molecular mechanisms of action of diuretics in each group is reviewed. The haemodynamic, humoral and physical factors involved in control of electrolyte and fluid handling by the kidney in normal conditions and pathological states are discussed in relation to rational choices of different diuretics in the treatment of various oedematous and non-oedematous conditions.
Similar content being viewed by others
References
Acchiardo, S.R. and Skoutakis, V.A.: Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment. American Heart Journal 106: 237–244 (1983).
Aiton, J.F.; Chipperfield, A.R.; Lamb, J.F.; Ogden, P. and Simons, N.L.: Occurrence of passive furosemide-sensitive transmembrane potassium transport in cultured cells. Biochimica et Biophysica Acta 646: 389–398 (1981).
Allgulander, C.; Beermann, B. and Sjögren, A.: Frusemide pharmacokinetics in patients with liver disease. Clinical Pharmacokinetics 5: 570–575 (1980).
Andreasen, F.; Hansen, U.; Husted, S.E. and Jansen, J.A.: The pharmacokinetics of frusemide are influenced by age. British Journal of Clinical Pharmacology 6: 391–397 (1983).
Andreasen, F. and Mickelsen, P.: Determination of furosemide in blood plasma and its binding to proteins in normal plasma from patients with acute renal failure. Acta Pharmacologica et Toxicologica 35: 49–57 (1974).
Anggard, E. and Oliw, E.: Formation and metabolism of prostaglandins in the kidney. Kidney International 19: 771–780 (1981).
Asbury, M.J.; Gatenby, P.B.B.; O’Sullivan, S. and Bourke, E.: Bumetanide: Potent new ‘Loop’ diuretic. British Medical Journal 1: 211–213 (1972).
Attalah, A.A.: Interaction of prostaglandins with diuretics. Prostaglandins 18: 369–375 (1979).
Baer, J.E. and Beyer, K.H.: Subcellular pharmacology of natriuretic and potassium-sparing drugs. Progress in Biochemistry and Pharmacology 7: 59–93 (1972).
Bailie, M.D.; Crosslan, K. and Hook, J.B.: Natriuretic effect of furosemide after inhibition of prostaglandins synthetase. Journal of Pharmacology and Experimental Therapeutics 199: 469–476 (1976).
Barger, A.C. and Sparks Jr, H.V.: Renal haemodynamics in congestive cardiac failure; in Lant and Wilson (Eds) Modern Diuretic Therapy in the Treatment of Cardiovascular and Renal Disease, pp.3–24 (Excerpta Medica, Amsterdam 1973).
Beermann, B.; Dalen, E.; Lindstrom, B. and Rosen, A.: On the fate of furosemide in man. European Journal of Clinical Pharmacology 9: 57–61 (1975).
Bcermann, B. and Groschinsky-Grind, M.: Pharmacokinetics of hydrochlorothiazide in patients with congestive failure. British Journal of Clinical Pharmacology 7: 579–583 (1979).
Beermann, B. and Groschinsky-Grind, M.: Clinical pharmacokinetics of diuretics. Clinical Pharmacokinetics 5: 221–245 (1980).
Beermann, B.; Groschinsky-Grind, M. and Lindstrom, B.: Pharmacokinetics of bendroflumethiazide. Clinical Pharmacology and Therapeutics 22: 385–388 (1977).
Belair, E.J.; Cohen, A.I. and Yelnosky, J.: Renal excretion of metolazone, a new diuretic. British Journal of Pharmacology 45: 476–479 (1972).
Bengtsson, C.; Johnsson, G.; Sannerstedt, R. and Werko, L.: Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. British Medical Journal 1: 197–199 (1975).
Berg, K.J.; Walstad, R.A. and Bergh, K.: The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. British Journal of Clinical Pharmacology 15: 347–353 (1983).
Beyer, K.H.; Baer, J.E.; Michaelson, J.K. and Russo, H.F.: Renotropic characteristics of ethacrynic acid: A phenoxyacetic saluretic-diuretic agent. Journal of Pharmacology and Experimental Therapeutics 147: 1–22 (1965).
Blantz, R.C. and Pelayo, J.C.: A functional role for the tubuloglomerular feedback mechanism. Kidney International 25: 739–746 (1984).
Bourland, W.A.; Day, D.K. and Williamson, H.E.: The role of the kidney in the early non-diuretic action of furosemide to reduce left atrial pressure in the hypervolemic dog. Journal of Pharmacology and Experimental Therapeutics 202: 211–229 (1977).
Branch, R.A.; Read, P.R.; Levine, D.; Elst, E.V.; Shelton, J.; Rupp, W. and Ramsay, L.E.: Furosemide and bumetanide: A study of responses in normal English and German subjects. Clinical Pharmacology and Therapeutics 19: 538–545 (1976).
Brater, D.C.: Increase in diuretic effect of chlorothiazide by probenecid. Clinical Pharmacology and Therapeutics 23: 259–265 (1978).
Brater, D.C.: Renal sites of action of azosemide. Clinical Pharmacology and Therapeutics 25: 428–434 (1979a).
Brater, D.C.: Analysis of the effect of indomethacin on the response to frusemide in man: Effect of dose of furosemide. Journal of Pharmacology and Experimental Therapeutics 210: 386–390 (1979b).
Brater, D.C.: Pharmacodynamic considerations in the use of diuretics. Annual Review of Pharmacology and Toxicology 23: 45–62 (1983).
Brater, D.C.; Anderson, S.A. and Strowing, S.: Azosemide, a ‘loop’ diuretic, and furosemide. Clinical Pharmacology and Therapeutics 25: 435–439 (1979).
Brater, D.C. and Chennavasin, P.: Effects of probenecid on response to bumetanide in man. Journal of Clinical Pharmacology 21: 311–315 (1981).
Brater, D.C.; Chennavasin, P.; Day, B.; Burdett, A. and Anderson, S.: Bumetanide and furosemide. Clinical Pharmacology and Therapeutics 34: 207–213 (1983a).
Brater, D.C.; Day, B.; Anderson, S.A. and Seiwell, R.: Azosemide kinetics and dynamics. Clinical Pharmacology and Therapeutics 34: 454–458 (1983b).
Brazier, J.L.; Pozet, N.; Faucon, G.; Traeger, J. and Hadj Aissa, A.: Kinetics of a high dose of piretanide in renal failure. European Journal of Clinical Pharmacology 21: 307–310 (1982).
Brazy, P.C. and Gunn, R.B.: Furosemide inhibition of chloride transport in human red blood cells. Journal of General Physiology 68: 583–599 (1976).
Brogden, R.N.; Speight, T.M. and Avery, G.S.: Mefruside: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema and hypertension. Drugs 7: 419–425 (1974).
Brogden, R.N.; Speight, T.M. and Avery, G.S.: Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema. Drugs 9: 4–18 (1975).
Brooks, B.A. and Lant, A.F.: The use of the human erythrocyte as a model for studying the action of diuretics on sodium and chloride transport. Clinical Science and Molecular Medicine 54: 679–683 (1978).
Brooks, B.A.; Blair, E.M.; Finch, R. and Lant, A.F.: Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196). British Journal of Clinical Pharmacology 10: 249–258 (1980).
Brooks, B.A.; Lant, A.F.; McNabb, W.J. and Noormohamed, F.H.: Stereo-specificity of diuretic receptors in the nephron — a study of the enantiomers of indacrinone (MK196) in man. Renal Physiology 7: 304–310 (1984b).
Brooks, B.A.; Lant, A.F.; McNabb, W.R. and Noormohamed, F.H.: Renal actions of uricosuric diuretic, racemic indacrinone, in man: Comparison with ethacrynic acid and hydrochlorothiazide. British Journal of Clinical Pharmacology 17: 497–512 (1984a).
Brors, O.; Jacobsen, S. and Arnesen, E.: Pharmacokinetics of a single oral dose of muzolimine in cardiac failure. European Journal of Clinical Pharmacology 14: 29–37 (1978).
Brors, O.; Jacobsen, S. and Arnesen, E.: Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure. European Journal of Clinical Pharmacology 15: 105–108 (1979).
Burke, T.J. and Duchin, K.: Glomerular filtration during furosemide diuresis in the dog. Kidney International 16: 672–680 (1979).
Burg, M.B.: Tubular chloride transport and the mode of the action of some diuretics. Kidney International 9: 189–197 (1976).
Burg, M.B. and Green, N.: Function of the thick ascending limb of Henle’s Loop. American Journal of Physiology 224: 659–669 (1973).
Burg, M.; Stoner, L.; Cardinal, J. and Green, N.: Furosemide effect on isolated perfused tubules. American Journal of Physiology 225: 119–124 (1973).
Campbell, D.B. and Moore, R.A.: The pharmacology and clinical pharmacology of indapamide. Postgraduate Medical Journal 57 (Suppl. 2): 7–17 (1981).
Campbell, D.B.; Taylor, A.R.; Hopkins, Y.W. and Williams, J.R.B.: Pharmacokinetics and metabolism of indapamide: A review. Current Medical Research and Opinion 5 (Suppl. 1): 13–24 (1977).
Candia, O.A.: The active translocation of Cl and Na by the frog corneal epithelium: Cotransport or separate pumps; in Zadunaisky (Ed.) Chloride Transport in Biological Membranes, pp.223–242 (Academic Press, New York 1982).
Chaffman, M.; Heel, R.C.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Indapamide: A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 28: 189–235 (1984).
Chennavasin, P.; Seiwell, R.; Brater, D.C. and Liang, W.M.M.: Pharmacodynamic analysis of the furosemide-probenecid interaction in man. Kidney International 16: 187–195 (1979).
Chennavasin, P.; Seiwell, R. and Brater, D.C.: Pharmacokineticdynamic analysis of the indomethacin-furosemide interaction in man. Journal of Pharmacology and Experimental Therapeutics 215: 77–81 (1980).
Chonko, A.M.; Bay, W.H.; Stein, J.H. and Ferris, T.F.: The role of renin and aldosterone in the salt retention of edema. American Journal of Medicine 63: 881–889 (1977).
Cinotti, G.A.: Interactions of renin, kinins and prostaglandins. Journal of Hypertension 1 (Suppl. 1): 43–51 (1983).
Cragoe, E.J.: Structure-activity relationship in the amiloride series; in Cuthbert et al. (Eds) Amiloride and Epithelial Sodium Transport, pp. 1–20 (Urban and Schwarzenberg, Baltimore, 1979).
Cragoe, E.J. (Ed.): Diuretic Agents. ACS Symposium Series No. 83 (American Chemical Society, Washington 1978).
Cragoe, E.J. (Ed.): Diuretics. Chemistry, Pharmacology, and Medicine (John Wiley and Sons, New York 1983a).
Craven, P.A. and DeRubertis, F.R.: Calcium-dependent stimulation of renal medullary prostaglandin synthesis by furosemide. Journal of Pharmacology and Experimental Therapeutics 222: 306–314 (1982).
Cunarro, J.A. and Weiner, M.W.: Effects of ethacrynic acid and furosemide on respiration of isolated kidney tubules: The role of ion transport and the source of metabolic energy. Journal of Pharmacology and Experimental Therapeutics 206: 198–206 (1978).
Cutler, R.E. and Blair, A.D.: Clinical pharmacokinetics of frusemide. Clinical Pharmacokinetics 4: 279–296 (1979).
Dal Canton, A.; Russo, D.; Gallo, R.; Conte, G. and Andreucci, V.E.: Muzolimine: A new high-ceiling diuretic suitable for patients with advanced renal disease. British Medical Journal 282: 595–598 (1981).
Dargie, H.J.; Boddy, K.; Kennedy, A.C.; King, P.C.; Read, P.R. and Ward, D.M.: Total body potassium in long-term frusemide therapy: Is potassium supplementation necessary? British Medical Journal 4: 316–319 (1974).
Dargie, H.J.; Allison, M.E.M.; Kennedy, A.C. and Gray, M.J.B.: High dose metolazone in chronic renal failure. British Medical Journal 4: 196–198 (1972).
Data, J.L.; Rane, A.; Gerkens, J.; Wilkinson, G.R.; Nies, A.S. and Branch, R.A.: The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog. Journal of Pharmacology and Experimental Therapeutics 206: 431–438 (1978).
Davies, D.L.; Lant, A.F.; Millard, N.R.; Smith, A.J.; Ward, J.W. and Wilson, G.M.: Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clinical Pharmacology and therapeutics 15: 141–155 (1974).
Davies, D.L. and Wilson, G.M.: Diuretics: Mechanism of action and clinical application. Drugs 9: 178–226 (1975).
De Wardener, H.E.: Natriuretic hormone. Clinical Science 52: 1–8 (1977).
De Wardener, H.E. and Clarkson, E.M.: The natriuretic hormone: Recent developments. Clinical Science 63: 415–420 (1982).
DiBona, G.F.: Neural control of renal tubular sodium reabsorption. American Journal of Physiology 233: F73–F81 (1977).
Dieterle, W.; Wagner, J. and Faigle, J.W.: Binding of chlorthalidone (Hygroton) to blood components in man. European Journal of Clinical Pharmacology 10: 37–42 (1976).
Dixon, W.R.; Young, R.L.; Holazo, A.; Jack, M.L.; Weinfeld, R.E.; Alexander, K.; Liebman, A. and Kaplan, S.A.: Bumetanide: Radioimmunoassay and pharmacokinetic profile in humans. Journal of Pharmaceutical Sciences 65: 701–704 (1976).
Duchin, K.L. and Hutcheon, D.E.: Distribution of intracortical renal blood flow induced by bumetanide in the dog. Journal of Pharmacology and Experimental Therapeutics 204: 135–140 (1978).
Dunham, P.D.; Stewart, G.W. and Ellory, J.C.: Chloride-activated passive potassium transport in human erythrocytes. Proceedings of the National Academy of Science 77: 1711–1715 (1980).
Dunn, M.J.: Ouabain-uninhibited sodium transport in human erythrocytes. Journal of Clinical Investigation 52: 658–670 (1973).
Dunn, M.J. and Hood, V.L.: Prostaglandins and the kidney. American Journal of Physiology 233: F169–F184 (1977).
Dunn, M.J. and Zambraski, E.J.: Renal effects of drugs that inhibit prostaglandins synthesis. Kidney International 18: 609–622 (1980).
Dyckner, T. and Wester, P.O.: Intracellular magnesium loss after diuretic administration. Drugs 28 (Suppl. 1): 161–166 (1984).
Eide, I.; Loyning, E.; Langard, O. and Kill, F.: Influence of ethacrynic acid on intrarenal renin release mechanisms. Kidney International 8: 158–165 (1975).
Eigler, J.; Kelter, J. and Renner, E.: Wirkungscharacteristika eines neuen Acylguanidins-Amilorid-HC1 (MK-870) an der isolierten Haut von Amphibien. Klinische Wochenschrift 14: 737–738 (1967).
Eknoyan, G.; Sawa, H.; Hyde III, S.; Wood, J.M.; Schwartz, A. and Suki, W.: Effects of diuretics on oxidative phosphorylation of dog kidney mitochondria. Journal of Pharmacology and Experimental Therapeutics 194: 614–623 (1975).
Ellory, J.C. and Stewart, G.W.: The human erythrocyte CL-de-pendent Na-K cotransport system as a possible model for studying the action of loop diuretics. British Journal of Pharmacology 75: 183–188 (1982).
Epstein, F.H.: Role of sodium-potassium-ATPase in sodium reabsorption by the kidney; in Lant and Wilson (Eds) Modern Diuretic Therapy in the Treatment of Cardiovascular and Renal Disease, pp. 188–193 (Excerpta Medica, Amsterdam 1973).
Eveloff, J.; Bayerdorffer, E.; Silva, P. and Kinne, R.: Sodium-chloride transport in the thick ascending limb of Henle’s loop. Pflugers Archiv 389: 263–270 (1981).
Eveloff, J. and Kinne, R.: Sodium-chloride transport in the medullary thick ascending limb of Henle’s loop: Evidence of a sodium-chloride co-transport system in plasma membrane vesicles. Journal of Membrane Biology 72: 173–181 (1983).
Fanelli Jr, G.M.; Bohn, D.L.; Scriabine, A. and Beyer Jr, D.H.: Saluretic and uricosuric effects of (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee. Journal of Pharmacology and Experimental Therapeutics 200: 402–412 (1977a).
Fanelli Jr, G.M.; Bohn, D.L. and Zacchei, A.G.: Renal excretion of saluretic-uricosuric agent (MK-196) and interaction with a urate retaining drug, pyrazinoate, in the chimpanzee. Journal of Pharmacology and Experimental Therapeutics 200: 413–419 (1977b).
Favre, L.; Glasson, P.H.; Riondel, A. and Vallotton, B.: Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. Clinical Science 54: 407–415 (1983).
Feit, P.W.: Aminobenzoic acid diuretics 2. 4-substituted-3-amino-5-sulfamylbenzoic acid derivatives. Journal of Medicinal Chemistry 14: 423–439 (1971).
Feit, P.W.: Structure-activity relationships of sulphamoyl diuretics. Postgraduate Medical Journal 51: 9–13 (1975).
Feit, P.W.: Diuretics: Encyclopedia of Chemical Technology, vol. 8, 3rd ed, pp. 1–33 (John Wiley, New York 1979).
Feris, E.D.: Salt in hypertension and the effects of diuretics. Annual Review of Pharmacology and Toxicology 19: 13–23 (1979).
Fernandez, P. and Puschett, J.B.: Proximal tubular actions of metolazone and chlorothiazide. American Journal of Physiology 225: 945–961 (1973).
Fine, L.G. and Kirschenbaum, M.A.: Absence of direct effects of prostaglandins on sodium chloride transport in the mammalian nephron. Kidney International 19: 797–801 (1981).
Fleuren, H.L.J. and Van Rossum, J.M.: Determination of chlorthalidone in plasma, urine and red blood cells by gas chromatography with nitrogen detection. Journal of Chromatography 152: 41–54 (1978).
Fleuren, H.L.J.; Van-Verwey Wissen, C.P.W, and Van Rossum, J.M.: Quantitative gas Chromatographie determination of two oxidized metabolites of the diuretic mefruside in human urine, plasma and red blood cells. Journal of Chromatography 182: 179–190 (1980).
Frazier, H.S. and Yager, H.: The clinical use of diuretics (first of two parts). New England Journal of Medicine 288: 246–249 (1973a).
Frazier, H.S. and Yager, H.: The clinical use of diuretics (second of two parts). New England Journal of Medicine 288: 455–457 (1973a).
Freeman, R.H.; Davis, J.P. and Villarreal, D.: Role of renal prostaglandins in the control of renin release. Circulation Research 54: 1–9 (1984).
Friedman, P.A. and Roch-Ramel, F.: Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat. Journal of Pharmacology and Experimental Therapeutics 203: 82–91 (1977).
Frizzell, R.A.; Field, M. and Schultz, S.: Sodium-coupled chloride transport by epithelial tissue. American Journal of Physiology 236: F1–F8 (1979).
Frizzell, R.A., Koch, M.J. and Schultz, S.G.: Ion transport by rabbit colon, I. Active and passive components. Journal of Membrane Biology 27: 297–316 (1976).
Gerber, J.G.: Role of prostaglandins in the hemodynamic and tubular effects of furosemide. Federation Proceedings 42: 1707–1710 (1983).
Gerber, J.G.; Nies, A.S. and Olson, R.D.: Control of canine renin release: Macula densa requires prostaglandin synthesis. Journal of Physiology 319: 419–429 (1981a).
Gerber, J.G.; Olson, R.D. and Nies, A.S.: Interrelationship between proslaglandins and renin release. Kidney International 19: 816–821 (1981b).
Gold, C.H. and Viljoen, M.: Site of renal action of xipamide. Clinical Pharmacology and Therapeutics 25: 522–527 (1979).
Goldberg, M.: The renal physiology of diuretics; in Handbook of Physiology, Section 8: Renal Physiology, pp. 1003–1031 (American Physiological Society, 1973).
Goldberg, M.; Beck, L.H.; Puschett, J.B. and Schubert, J.J.: Sites of action of benzothiadiazines, frusemide and ethacrynic acid; in Lant and Wilson (Eds) Modern Diuretic Therapy in the Treatment of Cardiovascular and Renal Disease pp. 135–144 (Excerpta Medica, Amsterdam 1973).
Goldberg, M.; McCurdy, D.K.; Foltz, E.L. and Bluemle, L.W.: Effects of ethacrynic acid (a new saluretic agent) on renal diluting and concentrating mechanisms. Evidence for site of action in the loop of Henle. Journal of Clinical Investigation 43: 201–216 (1964).
Grebow, P.E.; Treitman, J.A.; Barry, E.P.; Blasucci, D.J.; Portelli, S.T.; Tantillo, N.C.; Vukovich, R.A. and Neiss, E.S.: Pharmacokinetics and bioavailability of indapamide — a new antihypertensive drug. European Journal of Clinical Pharmacology 22: 295–299 (1982).
Greger, R.: Chloride reabsorption in the rabbit cortical thick ascending limb of the loop of Henle. Pflügers Archiv 390: 38–43 (1981).
Greger, R. and Schlatter, E.: Properties of the lumen membrane of the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflügers Archiv 396: 315–324 (1983a).
Greger, R. and Schlatter, E.: Properties of the lumen membrane of the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflügers Archiv 396: 325–334 (1983b).
Greger, R.; Schlatter, E. and Lang, F.: Evidence of electroneutral sodium chloride cotransport in the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflügers Archiv 396: 308–314 (1983).
Greven, J.: Studies on the renal receptors of loop diuretics. Clinical and Experimental Hypertension A5(2): 193–208 (1983).
Greven, J.; Beckers, M.; Defrain, W.; Meywald, K. and Heidenreich, O.: Studies with the optically active isomers of the new diuretic drug ozolinone. Pflügers Archiv 384: 61–64 (1980a).
Greven, J.; Defrain, W.; Glaser, K.; Meywald, K. and Heidenreich, O.: Studies with optically active isomers of the new diuretic drug ozolinone. Pflügers Archiv 384: 57–60 (1980b).
Gross, P.A.; Schrier, R.W. and Anderson, R.J.: Prostaglandins and water metabolism: A review with emphasis on in vivo studies. Kidney International 19: 839–850 (1981).
Haberle and Von Baeyer, H.: Characteristics of glomerulotubular balance. American Journal of Physiology 244: F355–F366 (1983).
Hadj Aissa, A.; Pozet, N.; Labeeuw, M.; Pellet, M. and Traeger, J.: Acute effect of a high dose (48mg) of piretanide in advanced renal insufficiency. British Journal of Pharmacology 11: 63–68 (1981).
Halladay, S.C.; Carter, D.E. and Sipes, I.G.: A relationship between the metabolism of bumetanide and its diuretic activity ir. the rat. Drug Metabolism and Disposition 6: 45–49 (1978).
Halladay, S.C.; Sipes, I.G. and Carter, D.E.: Diuretic effect and metabolism of bumetanide in man: Clinical Pharmacology and Therapeutics 22: 179–187 (1977).
Handler, J.S.: Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. Kidney International 19: 831–838 (1981).
Hebert, S.C. and Andreoli, T.E.: Control of NaCl transport in the thick ascending iimb. American Journal of Physiology 246: F745–F756 (1984).
Hempelmann, F.W. and Dieker, P.: Untersuchungen mit xipamid [4-chlor-5-sulfamoyl-2′,6′-salicyloxylidid]. Teil II. pharmacokinetik beim Menschen. Arzneimittel-Forschung 27: 2143–2151 (1977).
Henrich, W.L.: Role of prostaglandins in renin secretion. Kidney International 19: 822–830 (1981).
Higashio, T.: Abe, Y. and Yamamoto, K.: Renal effects of bumetanide. Journal of Pharmacology and Experimental Therapeutics 207: 212–220 (1978).
Hinsvark, O.N.; Zazulak, W. and Cohen, A.I.: Liquid chromatography: Its use in the biological characterization and study of metolazone — a new diuretic. Journal of Chromatographie Science 10: 379–383 (1972).
Hobbs, D.C. and Twomey, T.M.: Kinetics of polythiazide. Clinical Pharmacology and Therapeutics 23: 241–246 (1978).
Hoffman, E.K.: Anion exchange and anion-cation co-transport systems in mammalian cells. Philosphical Transactions of the Royal Society of London, Series B 299: 519–535 (1982).
Hoffman, J.F. and Kregenow, F.M.: The characterization of new energy dependent cation transport processes in red blood cells. Annals of the New York Academy of Sciences 137: 566–576 (1966).
Holland, S.D. and Williamson, H.E.: Probeneid inhibition of bumetanide induced natriuresis in the dog. Proceedings of the Society of Experimental Biology and Medicine 161: 299–302 (1979).
Homeida, M.; Roberts, C. and Branch, R.A.: Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man. Clinical Pharmacology and Therapeutics 22: 402–409 (1977).
Honari, J.; Blair, A.D. and Cutler, R.E.: Effects of probenecid on furosemide kinetics and natriuresis in man. Clinical Pharmacology and Therapeutics 22: 395–401 (1977).
Horstmann, H.; Cragoe (Ed.); Moller, E.; Wehinger, E. and Meng, K.: l-aralkyl-2-pyrazolin-5-ones: A new class of highly patent diuretics with high ceiling activity; in Diuretic Agents, pp. 125–154 (American Chemical Society, Washington 1978).
Hoyer, J.R. and Seiler, M.W.: Pathophysiology of Tamm-Horsfall protein. Kidney International 16: 279–189 (1979).
Ichikawa, I. and Brenner, B.M.: Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. Journal of Clinical Investigation 65: 1192–1201 (1980).
Ichikawa, I. and Brenner, B.M.: Glomerular actions of angiotensin II. American Journal of Medicine 76(5B): 43–49 (1984).
Imai, M.: Effect of bumetanide and furosemide on the thick ascending limb of Henle’s loop of rabbits and rats perfused in vitro. European Journal of Pharmacology 41: 409–416 (1977).
Jayakumar, S. and Puschett, J.B.: Study of the sites and mechanisms of action of bumetanide in man. Journal of Pharmacology and Experimental Therapeutics 201: 251–258 (1977).
Johnston, G.D.; Nicholls, D.P.; Leahey, W.J. and Finch, M.B.: The effects of captopril on the acute vascular responses to frusemide in man. Clinical Science 65: 359–363 (1983).
Karman, K.K.; Vaara, I.; Notstrand, B.; Lovgren, S.; Borell, A.; Fridborg, K. and Petef, M.: Structure and functions of cardiac anhydrase: Comparative studies of sulphonamide binding to human erythrocyte carbonic anhydrases B and C.; in Roberts (Ed.) Drug Action at the Molecular Level, pp.73–91 (Mac-Millan, London 1977).
Kaojarern, S.; Day, B. and Brater, D.C.: The time course of delivery of furosemide into urine: An independent determinant of overall response. Kidney International 22: 69–74 (1982).
Katz, A.I.: Renal Na-K-ATPase: Its role in tubular sodium and potassium transport. American Journal of Physiology 242: F207–F219 (1982).
Kaufman, J.; Hamburger, R.; Matheson, J. and Flamenbaum, W.: Bumetanide-induced diuresis and natriuresis: Effect of prostaglandin synthetase inhibition. Journal of Clinical Pharmacology 21: 663–667 (1981).
Kauker, M.L.: Clearance and micropuncture studies of the effects of a new indanyloxyacetic acid diuretic on segmental nephron function in rats. Journal of Pharmacology and Experimental Therapeutics 200: 81–87 (1977).
Kempson, S.A.; Kowalski, J.C. and Puschett, J.B.: Direct effect of metolazone on sodium-dependent transport across the renal brush border membrane. Journal of Laboratory and Clinical Medicine 101: 308–316 (1983).
Klahr, S.: The effect of diuretics on kidney intermediary metabolism; in Martinez-Maldonado (Ed.) Methods in Pharmacology, Vol. 4A, Renal Pharmacology, pp. 167–197 (Plenum, New York 1976).
Koechel, D.A. and Cafruny, E.J.: Thiol adducts of ethacrynic acid: A correlation of the rate of liberation of ethacrynic acid with the onset and magnitude of the diuretic response. Journal of Pharmacology and Experimental Therapeutics 192: 179–194 (1975).
Krück, F.; Badlok, W.; Besenfelder, E.; Betzien, G. and Kaufmann, B.: Clinical and pharmacological investigation of the-new saluretic azosemid. European Journal of Clinical Pharmacology 14: 153–161 (1978).
Kuhn, W. and Ryffel, K.: Herstellung Konzentrierter Losungen ans verdünnten durch blosse Membranewirkung: Ein Modelliversuch zur Function der Niere. Zeitschrift für Physiologische Chemie 276: 145–178 (1942).
Kunau, R.T.; Weller, D.R. and Webb, H.: Clarification of the site of action of chlorothiazide in the rat nephron. Journal of Clinical Investigation 56: 401–407 (1975).
Landon, E.J. and Fitzpatrick, D.F.: Ethacrynic acid and kidney cell metabolism. Biochemical Pharmacology 21: 1561–1568 (1972).
Lant, A.F.: Effects of bumetanide on cation and anion transport. Postgraduate Medical Journal 51: 35–42 (1975b).
Lant, A.F.: Diuretic therapy. Practitioner 219: 519–528 (1977).
Lant, A.F.: Modern diuretics and the kidney. Journal of Clinical Pathology 34: 1267–1275 (1981).
Lant, A.: Red cell chloride transport in relation to the action of diuretics, in Puschett and Greenberg (Eds) Diuretics: Chemistry, Pharmacology and Clinical Applications, pp. 313–319 (Elsevier, New York 1984).
Lant, A.F.; Baba, W.I. and Wilson, G.M.: On the clinical evaluation of diuretics with particular reference to a new phthalimidine diuretic, clorexolone. Clinical Pharmacology and Therapeutics 7: 196–211 (1966).
Lant, A.F.; Baba, W.I. and Wilson, G.M.: Localization of action of oral diuretics in the human kidney. Clinical Science 33: 11–27 (1967).
Lant, A.F. and Wilson, G.M.: Diuretics; in Black (Ed.) Renal Disease. 3rd ed., pp.655–704 (Blackwell Scientific, Oxford 1972).
Laragh, J.H. and Scalcy, J.E.: The renin-angiotensin-aldosterone hormonal system and regulations of sodium potassium, and blood pressure homcostasis; in Orloff and Berliner (Eds) Handbook of Physiology, Section 8, pp.831–908 (American Physiological Society, Washington 1973).
Lawrence, J.R.; Ansari, A.F.; Elliott, H.L.; Sumner, D.J.; Brunton, G.F.; Whiting, B. and Whitesmith, R.: Kinetic and dynamic comparison of piretanide and furosemide. Clinical Pharmacology and Therapeutics 23: 558–565 (1978).
Lau, H.S.H.; Shih, L.-J. and Smith, D.E.: Effect of probenecid on the dose-response relationship of bumetanide at steady state. Journal of Pharmacology and Experimental Therapeutics 227: 51–54 (1983).
Laubie, M. and Schmitt, H.: Comparison of the haemodynamic and autonomie effects of frusemide and indapamide and localization of the natriuretic action of indapamide. Current Medical Research and Opinion 5 (Suppl. 1): 89–100 (1977).
Loew, D. and Meng, K.: The renal mechanism of Bay g2821. Pharma-Therapeutica 1: 333–340 (1977).
Lubowitz, H.: The effect of bumetanide on cation transport in human red blood cells. Journal of Pharmacology and Experimental Therapeutics 203: 92–96 (1977).
Lubowitz, H. and Whittam, R.: Ion movements in human red cells independent of the sodium pump. Journal of Physiology 202: 111–131 (1969).
Marcantonio, L.A.; Auld, W.H.R.; Murdoch, W.R.; Purohit, R.; Skellern, G.G. and Howes, C.A.: The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease. British Journal of Clinical Pharmacology 15: 245–252 (1983).
Mark, K. and Burg, M.: Organization of nephron function. American Journal of Physiology 13: F579–F589 (1983).
Martinez-Maldonado, M. and Schwartz, A.: Renal ATPase as a receptor for drugs acting on the kidney; in Martinez-Maldonado (Ed.) Methods of Pharmacology, Vol. 4A, Renal Pharmacology, pp. 199–225 (Plenum, New York 1976).
McGiff, J.C.: Interactions of prostaglandins with the kallikreinkinin and renin-angiotensin systems. Clinical Science 59: 105S–116S (1980).
McGiff, J.C.; Spokas, E.C. and Y.-K.-Wong, P.: Stimulation of renin release by 6-oxo-prostaglandin E and prostacyclin. British Journal of Pharmacology 75: 137–144 (1982).
McNabb, W.R.; Noormohamed, F.H.; Brooks, B.A. and Lant, A.F.: Renal actions of piretanide and three other ‘loop’ diuretics in man. Clinical Pharmacology and Therapeutics 35: 328–337 (1984).
McNeil, J.J.; Drummer, O. and Louis, W.J.: Clopamide pharmacokinetics and effects on urinary electrolyte excretion. Clinical and Experimental Pharmacology and Physiology 10: 193–193 (1983).
Merkel, W.; Bormann, D.; Mania, D.; Muschaweck, R. and Hropot, M.: Piretanide (HOE-118), a new high ceiling salidiuretic. European Journal of Medicinal Chemistry 11: 399–406 (1976).
Morgan, T.O.: Diuretics: Basic clinical pharmacology and therapeutic use. Drugs 15: 151–158 (1978).
Motais, R. and Cousin, J.L.: Inhibitory effect of ethacrynic acid on chloride permeability. American Journal of Physiology 231: 1485–1489 (1976).
Mussche, M. and Lameire, N.: The mechanism of action of Bay g2821: A new diuretic. Current Medical Research and Opinion 4: 462–468 (1977).
Nascimento, L.; Ayala, J.M; Baquero, R.A. and Martinez-Maldonado, M.: Renin release by diuretics. Journal of Pharmacology and Experimental Therapeutics 208: 522–526 (1979).
Nechay, B.R.: Relationship between inhibition of renal Na+ plus K+-ATPase and natriuresis. Annals of the New York Academy of Sciences 242: 501–518 (1974).
Nechay, B.R.: Biochemical basis of diuretic action. Journal of Clinical Pharmacology 10: 626–641 (1977).
Nielsen, O.B.T. and Feit, P.W.: Structure-activity relationship of aminobenzoic acid diuretics and related compounds; in Cragoe (Ed.) Diuretic Agents, ACS Symposium 83, pp. 12–23 (American Clinical Society, Washington, 1978).
Nies, A.S.; Gal, J.; Fadul, S. and Gerber, J.G.: Indomethacinfurosemide interaction: The importance of renal blood flow. Journal of Pharmacology and Experimental Therapeutics 226: 27–32 (1983).
Novello, F.C. and Sprague, J.M.: Benzothiadiazine dioxides as novel diuretics. Journal of the American Chemical Society 79: 2028–2029 (1957).
Odlind, B.: Relationship between renal tubular secretion and effects of five loop diuretics. Journal of Pharmacology and Experimental Therapeutics 211: 238–244 (1979a).
Odlind, B.: Relationship between tubular secretion of furosemide and its saluretic effect. Journal of Pharmacology and Experimental Therapeutics 208: 515–521 (1979b).
Odlind, B.: Determinants of access of diuretics to their site of action. Federation Proceedings 42: 1703–1706 (1983).
Odlind, B. and Beermann, B.: Renal tubular secretion and effects of furosemide. Clinical Pharmacology and Therapeutics 27: 784–790 (1980).
Odlind, B.; Beermann, B.; Selen, G. and Persson, A.E.G.: Renal tubular secretion of piretanide and its effects on electrolyte reabsorption and tubuloglomerular feedback mechanism. Journal of Pharmacology and Experimental Therapeutics 225: 742–746 (1983).
Olsen, U.B.: Indomethacin inhibition of bumetanide diuresis in dog. Acta Pharmacologica et Toxicologica 37: 65–78 (1975).
Onesti, G.; Pitone, J.; Lowenthal, D.L.; Kim, K.E.; Affrime, M.; Bronstein, B.J.; Shirk, J.; Valvo, E.; Martinez, E.; Fernandes, M. and Swartz, C.: Studies on the natriuretic effect and site of action of indapamide. Current Medical Research and Opinion 5 (Suppl. 1): 83–88 (1977).
Orloff, J. and Zusman, R.: Role of prostaglandin E (PGE) in the modulation of the action of vasopressin on water flow in the urinary bladder of the toad and mammalian kidney. Journal of Membrane Biology 40: 297–304 (1978).
Orsoni, G.; Di Felice, A.; Cucudis, P.; Vangelista, A.; Stefoni, S. and Bonomini, V.: The use of muzolimine in chronic renal failure; in Andreucci (Ed.) Recent Advances in Diuretic Therapy, pp.246–255 (Excerpta Medica, Amsterdam 1983).
Østergaard, E.H.; Magnussen, M.P.; Nielsen, C.K.; Eilertsen, E. and Frey, H.H.: Pharmacological properties of 3N-butyl-amino-4-phenoxy-5-sulfamoyl-benzoic acid (bumetanide) a new potent diuretic. Arzneimittel-Forschung 22: 66–72 (1972).
Palfrey, H.C.; Feit, P.W. and Greengard, P.: cAMP-stimulated cation cotransport in avian erythrocytes: Inhibition by “Loop” diuretics. American Journal of Physiology 238: C139–C148 (1980).
Patak, R.V.; Fadem, S.Z.; Rosenblatt, S.G.; Lifschitz, M.D. and Stein, J.H.: Diuretic-induced changes in renal blood flow and prostaglandins E excretion in the dog. American Journal of Physiology 236: F494–F500 (1980).
Peach, M.J.: Renin-angiotensin system. Biochemistry and mechanisms of action. Physiological Reviews 57: 313–370 (1977).
Pentikainen, P.J.; Penttila, A.; Neuvonen, P.J. and Gothoni, G.: Fate of [l4C]-bumetanide in man. British Journal of Clinical Pharmacology 4: 39–44 (1977).
Perez, J.; Sitar, D.S. and Ogilvie, R.I.: Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema. British Journal of Clinical Pharmacology 9: 471–478 (1980).
Pozet, N.; Hadj-Aissa, A. and Pellet, M.: Activity of a new high efficiency diuretic in man: Piretanide (HOE 118). British Journal of Clinical Pharmacology 9: 577–583 (1980).
Proudfoot, A.D.; McNeil, J.J.; Drummer, O. and Louis, W.J.: Clopamide pharmacokinetics and effects on urinary electrolyte excretions, (abstract). Clinical and Experimental Pharmacology and Physiology 10: 193 (1983).
Pruitt, A.W.; Winkel, J.S. and Dayton, P.G.: Variations in the fate of triamterene. Clinical Pharmacology and Therapeutics 21: 610–619 (1977).
Puschett, J.R. and Greenberg, A. (Eds): Diuretics: Chemistry, Pharmacology and Clinical Applications (Elsevier, New York 1984).
Puschett, J.B. and Goldberg, M.: The acute effects of furosemide on acid and electrolyte excretion in man. Journal of Laboratory and Clinical Medicine 71: 666–677 (1968).
Puschett, J.B.; Steinmuller, S.R.; Rastegar, A. and Fernandez, P.: Metolazone: Mechanisms and sites of action; in Lant and Wilson (Eds) Modern Diuretic Therapy in the Treatment of Cardiovascular and Renal Disease, pp. 168–175 (Excerpta Medica, Amsterdam 1973).
Puschett, J.B.; Sylk, D. and Teredesai, P.R.: Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide. American Journal of Physiology 235: F403–F408 (1978).
Quamme, G.A.: Effect of furosemide on calcium and magnesium transport in the rat nephron. American Journal of Physiology 241: F340–F347 (1981).
Rector, F.: Sodium bicarbonate, and chloride absorption by the proximal tubule. American Journal of Physiology 13: F461–F471 (1983).
Reiss, W.; Dubach, U.C.; Burckhardt, p.; Theobald, W.; Vuillard, P. and Zimmerli, M.: Pharmacokinetic studies with chlorthalidonc (Hygroton) in man. European Journal of Clinical Pharmacology 12: 375–382 (1977).
Ritter, W.: Pharmacokinetics of Bay g2821 in the dog and in man. Current Medical Research and Opinion 4: 564–573 (1977).
Ritter, W.: Pharmacokinetics of muzolimine. Clinical Nephrology 19 (Suppl. 1): S26–S31 (1983).
Roberts, C.J.C.; Homeida, M. and Roberts, F.: Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects. British Journal of Clinical Pharmacology 6: 129–133 (1978).
Rocha, A.S. and Kokko, J.P.: Sodium chloride and water transport in the medullary thick ascending limb of Henle: Evidence for active chloride transport. Journal of Clinical Investigation 52: 612–623 (1973)
Röckel, A.: Diuretic effects of Bay g2821 in patients with advanced renal failure. Current Medical Research and Opinion 4: 574–579 (1977).
Rothstein, A. and Ramjeesingh, M.: The functional arrangement of the anion channel of red blood cells. Annals of the New York Academy of Sciences 358: 1–12 (1980).
Satzinger, G.; Herrmann, M.; Vollmer, K.O.; Merzweiler, A.; Gomahr, H.; Heildenreich, O. and Greven, J.: Etozolin: A novel diuretic; in Cragoe (Ed.) Diuretic Agents pp. 156–189 (American Chemical Society, Washington 1978).
Scherer, B. and Weber, P.C.: Time-dependent changes in prostaglandin excretion in response to frusemide in man. Clinical Science 56: 77–81 (1979).
Schlatter, E.; Greger, R. and Weidtke, C.: Effect of “high ceiling” diuretics on active salt transport in the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflugers Archiv 396: 210–217 (1983).
Schlondorff, D.; Zanger, R.; Stariano, J.A.; Folkert, V.W. and Eveloff, J.: Prostaglandin synthesis by isolated cells from the outer medulla and from the thick ascending loop of Henle of rabbit kidney. Journal of Pharmacology and Experimental Therapeutics 223: 120–154 (1982).
Schmidt, U. and Dubach, U.C.: Activity of Na+-K+-stimulated adenosine triphosphatase in the rat nephron. European Journal of Physiology 306: 219–226 (1969).
Schultz, E.M.; Cragoe, E.J.; Bicking, J.B.; Bolhofer, W.A. and Sprague, J.M.: α, β- Un saturated ketone derivatives of aryloxyacetic acids, a new class of diuretics. Journal of Medicinal Chemistry 5: 660–662 (1962).
Scriabinc, A.; Watson, L.S.; Russo, H.F.; Ludden, C.T.; Sweet, C.S.; Fanclli, G.M.; Bohidar, N.R. and Stone, C.A.: Diuretic and antihypertensive effects of 2-aminoethyl-4- (l,l-dimethylcthyl)-6-iodophenol hydrochloride (MK-447). Journal of Pharmacology and Experimental Therapeutics 208: 148–154 (1979).
Scely, J.F. and Dirks, J.H.: Site of action of diuretic drugs. Kidney International 11: 1–8 (1977).
Scldin, D.W.: Diuretic-induced potassium loss; in Andreucci (Ed.) Recent Advances in Diuretic Therapy, pp.9–20 (Excerpta Medica, Amsterdam 1982).
Shideman, J.R.; Zmuda, M.J. and Quebbemann, A.J.: The acute effects of furoscmide, ethacrynic acid and chlorothiazide on the renal tubular handling of uric acid in the chicken. Journal of Pharmacology and Experimental Therapeutics 216: 441–446 (1981).
Skorecki, K.L. and Brenner, B.M.: Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. American Journal of Medicine 22: 323–338 (1982).
Smith, R.L.; Schultz, E.M.; Stokker, G.E. and Cragoe Jr, E.J.: 2-Amino-methylphenols: A new class of saluretic agents; in Cragoc (Ed) Diuretic Agents, pp.93–124 (American Chemical Society, Washington 1978).
Sperber, I.: A new method for the study of renal tubular excretion in birds. Nature (London) 158: 131 (1946).
Stokes, J.B.: Potassium secretion by cortical collecting tubule: Relation to sodium absorption, luminal sodium concentration and transepithelial voltage. American Journal of Physiology 241: F395–F402 (1981).
Stone, K.J. and Hart, M.: Inhibition of renal PGE2-9-keto-reductase by diuretics. Prostaglandins 12: 197–207 (1976).
Sturm, K.; Siedel, W.; Weyer, R. and Ruschig, H.: Zur Chemie des Furosemids, I. Synthesen von 5-sulfamoyl-anthranilsaure-Derivaten. Chemische Berichte 99: 328–344 (1966).
Suki, W.; Rector, F.C. and Seldin, D.W.: The site of action of furosemide and other sulfonamide diuretics in the dog. Journal of Clinical Investigations 44: 1458–1469 (1965).
Teredesai, P. and Puschett, B.: Acute effects of piretanide in normal subjects. Clinical Pharmacology and Therapeutics 25: 331–339 (1979).
Tilstone, W.J. and Fine, A.: Furosemide kinetics in renal failure. Clinical Pharmacology and Therapeutics 23: 644–650 (1978).
Torretti, J.: Sympathetic control of renin release. Annual Review of Pharmacology and Toxicology 22: 167–192 (1982).
Valette, H.; Hebert, J.L.; Raffestin, B.; Lockhart, A. and Apoil, E.: Comparison of hemodynamic effects of furosemide and piretanide in normovolemic patients. Journal of Cardiovascular Pharmacology 2: 103–111 (1980).
Valtin, H.: Structural and functional heterogeneity of mammalian nephrons. American Journal of Physiology 233: F491–F501 (1977).
Velasquez, M.T.; Han Wan, S. and Marotnde, R.F.: Bumetanide-induced rise in plasma renin activity. Clinical Pharmacology and Therapeutics 24: 186–191 (1978).
Velasquez, M.T.; Han Wan, S.; Barr, J.W. and Maronde, R.F.: Effect of probenecid on the natriuresis and renin release induced by bumetanide in man. Journal of Clinical Pharmacology 21: 657–662 (1981).
Vose, C.W.; Stevens, P.M.; Murihead, D.C.; Palmer, R.F. and Mclnnes, G.T.: A fluorimetric assay for metolazone in urine. British Journal of Clinical Pharmacology 9: 213–215 (1980).
Wade, J.B.; Stetson, D.L. and Lewis, S.A.: ADH action: Evidence for a membrane shuttle mechanism. Annals of the New York Academy of Sciences 372: 106–117 (1981).
Ward, A. et al.: Bumetanide: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 28: 426–464 (1984).
Weber, P.C.; Scherer, B. and Larsson, C.: Increase of free arachidonic acid by furosemide in man as the cause of prostaglandins and renin release. European Journal of Pharmacology 41: 329–332 (1977).
Weinman, E.J.; Knight, T.F.; McKenzie, R. and Eknoyan, G.: Dissociation of urate from sodium transport in the rat proximal tubule. Kidney International 10: 295–300 (1976).
Weinman, E.J.; Senekjian, H.O. and Knight, T.F.: Effects of MK-196 on urate and electrolyte excretion in the rat. Nephron 23 (Suppl. 1): 21–24 (1979).
Wiley, J.S. and Cooper, R.A.: A furosemide-sensitive cotransport of sodium plus potassium in the human red cell. Journal of Clinical Investigation 53: 745–755 (1974).
Williamson, H.E.; Bourland, W.A. and Marchand, G.R.: Inhibition of furosemide induced increase in renal blood flow by indomethacin. Proceedings of the Society for Experimental Biology and Medicine 148: 164–167 (1975).
Wilson, C.B. and Kirkendall, M.: The acute effects of mefruside in man: A new diuretic compound. Journal of Pharmacology and Experimental Therapeutics 171: 288–299 (1970).
Winaver, J.; Sylk, D.B.; Teredesai, P.R.; Robertson, J.S. and Puschett, J.B.: Dissociative effects of piretanide on proximal tubular PO4 and HCO3 transport. American Journal of Physiology 238: F60–F68 (1980).
Windhager, E.E. and Giebisch, G.: Proximal sodium and fluid transport. Kidney International 9: 121–133 (1976).
Wirth, K.E.; Frolich, J.C.; Hollifield, J.W.; Falkner, F.C.; Sweetman, B.S. and Oates, J.A.: Metabolism of digitoxin in man and its modification by spironolactone. European Journal of Pharmacology 9: 345–354 (1976).
Wirz, H.; Hargitay, B. and Kuhn, W.: Lokalisation des Konzentrierungsprozesses in der Niere durch direkte Kryoscopie. Helvetica Physiologica et Pharmacologica Acta 9: 196–207 (1951).
Wright, F.S.: Intrarenal regulation of glomerular filtration rate. New England Journal of Medicine 291: 135–141 (1974).
Wright, F.S.: Sites and mechanisms of potassium transport along the renal tubule. Kidney International 11: 415–432 (1977).
Wright, F.S. and Briggs, J.P.: Feedback control of glomerular blood flow, pressure and filtration rate. Physiological Reviews 59: 958–1006 (1979).
Woltersdorf Jr, O.W.; De Solms, S.J. and Cragoe Jr, E.J.: The evolution of the (aryloxy) acetic acid diuretics; in Cragoe (Ed.) Diuretic Agents, ACS Symposium 83, pp. 190–230 (American Chemical Society, Washington 1978).
Yoshida, A.; Yamada, T. and Koshikawa, S.: Effect of diuretic on energy metabolism. Biochemical Pharmacology 20: 1933–1942 (1971).
Zacchei, A.G. and Wishousky, T.I.: The physiological disposition of the uricosuric saluretic agent (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxylacetic acid (MK-196) in the rat, dog and monkey. Drug Metabolism and Disposition 4: 490–498 (1976).
Zadunaisky, J.A.: Sodium activation of chloride transport in the frog cornea. Biochemica Biophysica Acta 282: 255–257 (1972).
Zanchetti, A.; Stella, A.; Leonetti, G.; Morganti, A. and Terzoli, L.: Control of renin release: A review of experimental evidence and clinical implications. American Journal of Cardiology 37: 675–691 (1976).
Zeuthen, T.; Ramos, M. and Ellory, J.C.: Inhibition of active chloride transport by piretanide. Nature 273: 678–680 (1978).
Author information
Authors and Affiliations
Additional information
First of two parts. Part II will appear in the following issue.
Rights and permissions
About this article
Cite this article
Lant, A. Diuretics. Drugs 29, 57–87 (1985). https://doi.org/10.2165/00003495-198529010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198529010-00003